OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Gastroenterology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Editorial introductions	58
Hepatitis E virus: has anything changed?	47
Medical malpractice and gastrointestinal endoscopy	47
The national institutes of health's approach to address research gaps in pancreatitis, diabetes and early detection of pancreatic cancer	37
Single-use duodenoscopes: where are we and where are we going?	30
Editorial introductions	30
Biologics, small molecule therapies and surgery in small bowel Crohn's disease	29
Clostridioides difficile infections; new treatments and future perspectives	27
Small varices in chronic liver diseases	24
Updates and innovations in therapeutic endoscopy	23
Mucosal defense: gastroduodenal injury and repair mechanisms	23
Management of upper gastrointestinal symptoms in patients with autoimmune gastritis	22
Stomach and duodenum: what's current in 2023	21
Editorial introductions	21
Cholangioscopy for biliary diseases	21
Current and future microbiome-based therapies in inflammatory bowel disease	18
Carnitine derivatives beyond fatigue: an update	17
Double-edged sword: impact of fecal microbiome transplants on the gut resistome	17
Using nutrition to help recovery from infections	16
Tips for successful deep enteroscopy	15
Role of hyperbaric oxygen therapy in patients with inflammatory bowel disease	15
Micronutrient status and protein-energy malnutrition in free-living older adults: a current perspective	15
Editorial: Clinical and pathogenic novelties in cholangiopathies: new treatments and many more to come	15
The gut virome in health and disease: new insights and associations	14
Interactions between the environmental and human microbiota in the preservation of health and genesis of disease: symposium report	13

Incorporating image enhanced endoscopy in your everyday practice	13
COVID-19 vaccine-induced liver injury	13
A brave new world: the gastrointestinal lab during and after a pandemic	13
Small bowel lymphoma: clinical update and challenges for the gastroenterologist	13
Refractory eosinophilic esophagitis: what to do when the patient has not responded to proton pump inhibitors, steroids and diet	12
Considerations when starting patients on multiple biologics and small molecules	12
The role of the allergist in the management of eosinophilic esophagitis	12
Cryptogenic multifocal ulcerating stenosing enteritis and other under-recognised small bowel inflammatory enteropathies	11
Prognostic modeling in biliary diseases	11
Clinical and translational markers of severity and prognosis in chronic pancreatitis	11
Implications of Paneth cell dysfunction on gastrointestinal health and disease	11
A review of deep learning and radiomics approaches for pancreatic cancer diagnosis from medical imaging	11
Endoscopic management of colonic perforations	10
Why antibiotics should not be used to treat Shiga toxin-producing Escherichia coli infections	10
Breastfeeding and the developmental origins of mucosal immunity: how human milk shapes the innate and adaptive mucosal immune systems	10
Gastric submucosal mass lesions	10
Gastroparesis: time for a paradigm change	10
Celiac disease and nonceliac enteropathies	9
Bidirectional relationship between acute pancreatitis and pancreatic cancer	9
Editorial introductions	9
Laparoscopic heller myotomy versus peroral endoscopic myotomy for the treatment of achalasia	9
Role of albumin in the treatment of decompensated liver cirrhosis	9
Tight junction proteins and biliary diseases	9
Editorial: No organ is an island: the role of gut–organ axes in human health and disease	9
Endoluminal bariatric and metabolic therapies: state-of-the-art	9
Ergonomic wellness for the trainee in gastrointestinal endoscopy	8
Editorial introductions	8
Diagnosis and management of acute lower gastrointestinal bleeding	8
Advances in the evaluation and treatment of autoimmune hepatitis	8
Histological evaluation in biliary diseases	8
Alterations in microbiome associated with acute pancreatitis	8
Machine and deep learning in inflammatory bowel disease	8
Artificial intelligence within the small bowel: are we lagging behind?	8
Intestinal proteases	8
Managing the older adult with inflammatory bowel disease: is age just a number?	8
Probiotics in irritable bowel syndrome and inflammatory bowel disease: review of mechanisms and effectiveness	7
Bile acid diarrhea – as bad as it gets?	7
Pathophysiology updates: gastroduodenal injury and repair mechanisms	7
Advances in endoscopic management of colonic diverticular bleeding	7
Endoscopic approaches to the management of hemorrhoids	7
Check this out: treatment paradigms in immune-checkpoint inhibitor colitis	7
The spectrum of diabetes in acute and chronic pancreatitis	7
Nutritional aspects in patients with gastroparesis	7
The rise of antibiotic resistance in Campylobacter	7
Endoscopic approaches to small intestinal strictures	7
The status of endoscopic therapies for gastroesophageal reflux disease	6
Diet and carcinogenesis of gastric cancer	6
Editorial introductions	6
Editorial: Advances in hepatology: 2022	6
Management of the patient with esophagogastric junction outflow obstruction	6

Should high-fiber diets be recommended for patients with inflammatory bowel disease?	6
Updates on therapeutic endoscopic ultrasound	6
Update on applications of endoscopic cryotherapy in the gastrointestinal tract	6
Celiac disease: clinical update	6
Updates in endoscopic management of ampullary and duodenal adenomas	6
Integrating new and emerging therapies into inflammatory bowel disease clinical practice	6
Imaging abnormalities of the pancreas in diabetes: implications for diagnosis and treatment	6